| Drug Type siRNA | 
| Synonyms- | 
| Target | 
| Action inhibitors | 
| Mechanism Bcl-2 inhibitors(Apoptosis regulator Bcl-2 inhibitors), MYC inhibitors(Myc proto-oncogene protein inhibitors) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhaseDiscovery | 
| First Approval Date- | 
| Regulation- | 

| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Lung Cancer | Discovery | South Korea  | 20 Apr 2023 | |
| Ovarian Cancer | Discovery | South Korea  | 20 Apr 2023 | 





